# Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

> **NCT07495098** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Vermont** · enrollment: 12 (estimated)

## Conditions studied

- Lung Cancer Metastatic
- Lung Cancer (NSCLC)

## Interventions

- **DRUG:** cisplatin (cis-diamminedichloroplatinum(II) (CDDP))

## Key facts

- **NCT ID:** NCT07495098
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2030-07-01
- **Final completion:** 2031-06-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07495098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07495098, "Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07495098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*